Mereo BioPharma Group plc
MREO
$1.77
$0.0251.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.62M | -12.89M | -7.05M | -15.00M | -12.26M |
| Total Depreciation and Amortization | 298.00K | 270.00K | 274.00K | 282.00K | 257.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.51M | 4.80M | -3.51M | 8.58M | 2.44M |
| Change in Net Operating Assets | -843.00K | -514.00K | 857.00K | -1.38M | 1.66M |
| Cash from Operations | -7.65M | -8.33M | -9.42M | -7.52M | -7.90M |
| Capital Expenditure | 0.00 | -20.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -300.00K | 0.00 | 0.00 | 1.00K |
| Cash from Investing | 0.00 | -320.00K | 0.00 | 0.00 | 1.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 487.00K | 0.00 | 0.00 | 47.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -134.00K | -65.00K | -40.00K | -594.00K | -219.00K |
| Cash from Financing | -134.00K | 422.00K | -40.00K | -594.00K | 46.78M |
| Foreign Exchange rate Adjustments | 1.43M | 908.00K | -1.26M | 1.20M | -107.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.36M | -7.32M | -10.72M | -6.91M | 38.77M |